Mylan Announces Settlement Deal For Generic Version Of Orapred ODT - Quick ... NASDAQ (RTTNews.com) - Mylan Inc. (MYL) announced that it has entered into a settlement agreement with Shionogi Inc. and CIMA Labs Inc. that will resolve patent litigation related to Prednisolone Sodium Phosphate Orally Disintegrating Tablets (ODT), 10 mg, ... |
